nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

25.02.2023 | Review

MicroRNAs in POI, DOR and POR

verfasst von: Jiali Luo, Zhaogui Sun

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. However, the etiology of approximately 90% patients remains unknown. Diminished ovarian reserve (DOR) and poor ovarian response (POR) are related to POI in clinic. The main purpose of this review was to evaluate the roles of microRNAs (miRNAs) in the pathogenesis and therapeutic potential for POI, DOR and POR.

Methods

A literature search was conducted using six databases (PubMed, EMBASE, Web of Science, Cochrane Library, CNKI and Wangfang Data) to obtain relevant studies.

Results

This review enlightens expression profiles and functional studies of miRNAs in ovarian insufficiency in animal models and humans. Functional studies emphasized the role of miRNAs in steroidogenesis, granulosa cell proliferation/apoptosis, autophagy and follicular development by regulating target genes in specific pathways, such as the PI3K/AKT/mTOR, TGFβ, MAPK and Hippo pathways. Differentially expressed circulating miRNAs provided novel biomarkers for diagnosis and prediction, such as miR-22-3p and miR-21. Moreover, exosomes derived from stem cells restored ovarian function through miRNAs in chemotherapy-induced POI models.

Conclusion

Differential miRNA expression profiles in patients and animal models uncovered the underlying mechanisms and biomarkers of ovarian insufficiency. Exosomal miRNAs can restore ovarian function against chemotherapy-induced POI, which needs further investigation to develop novel preventive and therapeutic strategies in clinical practice.

European Society for Human, R., Embryology Guideline Group on, P. O. I., Webber L et al (2016) Eshre guideline: management of women with premature ovarian insufficiency. Hum Reprod 31(5):926–937. https://doi.org/10.1093/humrep/dew027CrossRef

Golezar S, Ramezani Tehrani F, Khazaei S et al (2019) The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric 22(4):403–411. https://doi.org/10.1080/13697137.2019.1574738CrossRefPubMed

Nelson LM, Covington SN, Rebar RW (2005) An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 83(5):1327–1332. https://doi.org/10.1016/j.fertnstert.2004.11.059CrossRefPubMed

Welt CK (2008) Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 68(4):499–509. https://doi.org/10.1111/j.1365-2265.2007.03073.xCrossRefPubMed

Pastore LM, Christianson MS, Stelling J et al (2018) Reproductive ovarian testing and the alphabet soup of diagnoses: dor, poi, pof, por, and for. J Assist Reprod Genet 35(1):17–23. https://doi.org/10.1007/s10815-017-1058-4CrossRefPubMed

Sharara FI, Scott RT Jr, Seifer DB (1998) The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 179(3 Pt 1):804–812. https://doi.org/10.1016/s0002-9378(98)70087-0CrossRefPubMed

Ferraretti AP, La Marca A, Fauser BC et al (2011) Eshre consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the bologna criteria. Hum Reprod 26(7):1616–1624. https://doi.org/10.1093/humrep/der092CrossRefPubMed

Szmidt NA, Bhattacharya S, Maheshwari A (2016) Does poor ovarian response to gonadotrophins predict early menopause? A retrospective cohort study with minimum of 10-year follow-up. Hum Fertil (Camb) 19(3):212–219. https://doi.org/10.1080/14647273.2016.1221149CrossRefPubMed

Guo Y, Sun J, Lai D (2017) Role of micrornas in premature ovarian insufficiency. Reprod Biol Endocrinol 15(1):38. https://doi.org/10.1186/s12958-017-0256-3CrossRefPubMedPubMedCentral

10.

Pankiewicz K, Laudanski P, Issat T (2021) The role of noncoding rna in the pathophysiology and treatment of premature ovarian insufficiency. Int J Mol Sci. https://doi.org/10.3390/ijms22179336CrossRefPubMedPubMedCentral

11.

Ambros V (2004) The functions of animal micrornas. Nature 431(7006):350–355. https://doi.org/10.1038/nature02871CrossRefPubMed

12.

Ro S, Song R, Park C et al (2007) Cloning and expression profiling of small rnas expressed in the mouse ovary. RNA 13(12):2366–2380. https://doi.org/10.1261/rna.754207CrossRefPubMedPubMedCentral

13.

Kuang H, Han D, Xie J et al (2014) Profiling of differentially expressed micrornas in premature ovarian failure in an animal model. Gynecol Endocrinol 30(1):57–61. https://doi.org/10.3109/09513590.2013.850659CrossRefPubMed

14.

Ai A, Xiong Y, Wu B et al (2018) Induction of mir-15a expression by tripterygium glycosides caused premature ovarian failure by suppressing the hippo-yap/taz signaling effector lats1. Gene 678:155–163. https://doi.org/10.1016/j.gene.2018.08.018CrossRefPubMed

15.

Liu T, Liu Y, Huang Y et al (2019) Mir-15b induces premature ovarian failure in mice via inhibition of α-klotho expression in ovarian granulosa cells. Free Radic Biol Med 141:383–392. https://doi.org/10.1016/j.freeradbiomed.2019.07.010CrossRefPubMed

16.

Zhao H, Gu W, Pan W et al (2021) mir-483-5p aggravates cisplatin-induced premature ovarian insufficiency in rats by targeting fkbp4. Nan Fang Yi Ke Da Xue Xue Bao 41(6):801–810. https://doi.org/10.12122/j.issn.1673-4254.2021.06.01CrossRefPubMed

17.

Zhang X, Zhang R, Hao J et al (2022) Mirna-122-5p in poi ovarian-derived exosomes promotes granulosa cell apoptosis by regulating bcl9. Cancer Med 11(12):2414–2426. https://doi.org/10.1002/cam4.4615CrossRefPubMedPubMedCentral

18.

Liu C, Li Q, Yang Y (2019) Effects of the modified bazhen decoction in the treatment of premature ovarian failure in rats. Ann Clin Lab Sci 49(1):16–22PubMed

19.

Yang X, Zhou Y, Peng S et al (2012) Differentially expressed plasma micrornas in premature ovarian failure patients and the potential regulatory function of mir-23a in granulosa cell apoptosis. Reproduction 144(2):235–244. https://doi.org/10.1530/REP-11-0371CrossRefPubMed

20.

Kim YJ, Ku SY, Kim YY et al (2013) Micrornas transfected into granulosa cells may regulate oocyte meiotic competence during in vitro maturation of mouse follicles. Hum Reprod 28(11):3050–3061. https://doi.org/10.1093/humrep/det338CrossRefPubMed

21.

Tao H, Wang L, Zhou J et al (2015) The transcription factor ccaat/enhancer binding protein β (c/ebpβ) and mir-27a regulate the expression of porcine dickkopf2 (dkk2). Sci Rep 5:17972. https://doi.org/10.1038/srep17972CrossRefPubMedPubMedCentral

22.

Tao H, Xiong Q, Ji Z et al (2019) Nfat5 is regulated by p53/mir-27a signal axis and promotes mouse ovarian granulosa cells proliferation. Int J Biol Sci 15(2):287–297. https://doi.org/10.7150/ijbs.29273CrossRefPubMedPubMedCentral

23.

Liu T, Lin J, Chen C et al (2021) Microrna-146b-5p overexpression attenuates premature ovarian failure in mice by inhibiting the dab2ip/ask1/p38-mapk pathway and gammah2a.X phosphorylation. Cell Prolif 54(1):e12954. https://doi.org/10.1111/cpr.12954CrossRefPubMed

24.

Zhang M, Zhang Q, Hu Y et al (2017) Mir-181a increases foxo1 acetylation and promotes granulosa cell apoptosis via sirt1 downregulation. Cell Death Dis 8(10):e3088. https://doi.org/10.1038/cddis.2017.467CrossRefPubMedPubMedCentral

25.

Zhang C, Shen J, Kong S et al (2019) Microrna-181a promotes follicular granulosa cell apoptosis via sphingosine-1-phosphate receptor 1 expression downregulation†. Biol Reprod 101(5):975–985. https://doi.org/10.1093/biolre/ioz135CrossRefPubMed

26.

Zhang Q, Sun H, Jiang Y et al (2013) Microrna-181a suppresses mouse granulosa cell proliferation by targeting activin receptor iia. PLoS ONE 8(3):e59667. https://doi.org/10.1371/journal.pone.0059667CrossRefPubMedPubMedCentral

27.

Zhang JQ, Gao BW, Guo HX et al (2020) Mir-181a promotes porcine granulosa cell apoptosis by targeting tgfbr1 via the activin signaling pathway. Mol Cell Endocrinol 499:110603. https://doi.org/10.1016/j.mce.2019.110603CrossRefPubMed

28.

Dang Y, Zhao S, Qin Y et al (2015) Microrna-22-3p is down-regulated in the plasma of han chinese patients with premature ovarian failure. Fertil Steril 103(3):802-807.e801. https://doi.org/10.1016/j.fertnstert.2014.12.106CrossRefPubMed

29.

Sirotkin AV, Laukova M, Ovcharenko D et al (2010) Identification of micrornas controlling human ovarian cell proliferation and apoptosis. J Cell Physiol 223(1):49–56. https://doi.org/10.1002/jcp.21999CrossRefPubMed

30.

Xiong F, Hu L, Zhang Y et al (2016) Mir-22 inhibits mouse ovarian granulosa cell apoptosis by targeting sirt1. Biol Open 5(3):367–371. https://doi.org/10.1242/bio.016907CrossRefPubMedPubMedCentral

31.

Zhang X, Dang Y, Liu R et al (2020) Microrna-127-5p impairs function of granulosa cells via hmgb2 gene in premature ovarian insufficiency. J Cell Physiol 235(11):8826–8838. https://doi.org/10.1002/jcp.29725CrossRefPubMed

32.

Dang Y, Wang X, Hao Y et al (2018) Microrna-379-5p is associate with biochemical premature ovarian insufficiency through parp1 and xrcc6. Cell Death Dis 9(2):106. https://doi.org/10.1038/s41419-017-0163-8CrossRefPubMedPubMedCentral

33.

Zhao G, Zhou X, Fang T et al (2014) Hyaluronic acid promotes the expression of progesterone receptor membrane component 1 via epigenetic silencing of mir-139-5p in human and rat granulosa cells. Biol Reprod 91(5):116. https://doi.org/10.1095/biolreprod.114.120295CrossRefPubMed

34.

Chen X, Xie M, Liu D et al (2015) Downregulation of microrna146a inhibits ovarian granulosa cell apoptosis by simultaneously targeting interleukin1 receptorassociated kinase and tumor necrosis factor receptorassociated factor 6. Mol Med Rep 12(4):5155–5162. https://doi.org/10.3892/mmr.2015.4036CrossRefPubMed

35.

Abd El Naby WS, Hagos TH, Hossain MM et al (2013) Expression analysis of regulatory micrornas in bovine cumulus oocyte complex and preimplantation embryos. Zygote 21(1):31–51. https://doi.org/10.1017/S0967199411000566CrossRefPubMed

36.

Nie M, Yu S, Peng S et al (2015) Mir-23a and mir-27a promote human granulosa cell apoptosis by targeting smad5. Biol Reprod 93(4):98. https://doi.org/10.1095/biolreprod.115.130690CrossRefPubMed

37.

Luo H, Han Y, Liu J et al (2019) Identification of micrornas in granulosa cells from patients with different levels of ovarian reserve function and the potential regulatory function of mir-23a in granulosa cell apoptosis. Gene 686:250–260. https://doi.org/10.1016/j.gene.2018.11.025CrossRefPubMed

38.

Assou S, Al-edani T, Haouzi D et al (2013) Micrornas: new candidates for the regulation of the human cumulus-oocyte complex. Hum Reprod 28(11):3038–3049. https://doi.org/10.1093/humrep/det321CrossRefPubMed

39.

Li X, Xie J, Wang Q et al (2020) Mir-21 and pellino-1 expression profiling in autoimmune premature ovarian insufficiency. J Immunol Res 2020:3582648. https://doi.org/10.1155/2020/3582648CrossRefPubMedPubMedCentral

40.

Zhang X, Chen Y, Yang M et al (2020) Mir-21-5p actions at the smad7 gene during pig ovarian granulosa cell apoptosis. Anim Reprod Sci 223:106645. https://doi.org/10.1016/j.anireprosci.2020.106645CrossRefPubMed

41.

Aldakheel FM, Abuderman AA, Alduraywish SA et al (2021) Microrna-21 inhibits ovarian granulosa cell proliferation by targeting snhg7 in premature ovarian failure with polycystic ovary syndrome. J Reprod Immunol 146:103328. https://doi.org/10.1016/j.jri.2021.103328CrossRefPubMed

42.

Fu X, He Y, Wang X et al (2017) Overexpression of mir-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting pdcd4 and pten to inhibit granulosa cell apoptosis. Stem Cell Res Ther 8(1):187. https://doi.org/10.1186/s13287-017-0641-zCrossRefPubMedPubMedCentral

43.

Ma L, Tang X, Guo S et al (2020) Mirna-21-3p targeting of fgf2 suppresses autophagy of bovine ovarian granulosa cells through akt/mtor pathway. Theriogenology 157:226–237. https://doi.org/10.1016/j.theriogenology.2020.06.021CrossRefPubMed

44.

Ma L, Zheng Y, Tang X et al (2019) Mir-21-3p inhibits autophagy of bovine granulosa cells by targeting vegfa via pi3k/akt signaling. Reproduction 158(5):441–452. https://doi.org/10.1530/REP-19-0285CrossRefPubMed

45.

Bartolucci AF, Uliasz T, Peluso JJ (2020) Microrna-21 as a regulator of human cumulus cell viability and its potential influence on the developmental potential of the oocyte. Biol Reprod 103(1):94–103. https://doi.org/10.1093/biolre/ioaa058CrossRefPubMed

46.

Hilker RE, Pan B, Zhan X et al (2021) Microrna-21 enhances estradiol production by inhibiting wt1 expression in granulosa cells. J Mol Endocrinol 68(1):11–22. https://doi.org/10.1530/JME-21-0162CrossRefPubMed

47.

Donadeu FX, Mohammed BT, Ioannidis J (2017) A mirna target network putatively involved in follicular atresia. Domest Anim Endocrinol 58:76–83. https://doi.org/10.1016/j.domaniend.2016.08.002CrossRefPubMedPubMedCentral

48.

Carletti MZ, Fiedler SD, Christenson LK (2010) Microrna 21 blocks apoptosis in mouse periovulatory granulosa cells. Biol Reprod 83(2):286–295. https://doi.org/10.1095/biolreprod.109.081448CrossRefPubMedPubMedCentral

49.

Dehghan Z, Mohammadi-Yeganeh S, Rezaee D et al (2021) Microrna-21 is involved in oocyte maturation, blastocyst formation, and pre-implantation embryo development. Dev Biol 480:69–77. https://doi.org/10.1016/j.ydbio.2021.08.008CrossRefPubMed

50.

Woo I, Christenson LK, Gunewardena S et al (2018) Micro-rnas involved in cellular proliferation have altered expression profiles in granulosa of young women with diminished ovarian reserve. J Assist Reprod Genet 35(10):1777–1786. https://doi.org/10.1007/s10815-018-1239-9CrossRefPubMedPubMedCentral

51.

Chen D, Zhang Z, Chen B et al (2017) Altered microrna and piwi-interacting rna profiles in cumulus cells from patients with diminished ovarian reserve. Biol Reprod 97(1):91–103. https://doi.org/10.1093/biolre/iox062CrossRefPubMed

52.

Hong L, Peng S, Li Y et al (2018) Mir-106a increases granulosa cell viability and is downregulated in women with diminished ovarian reserve. J Clin Endocrinol Metab 103(6):2157–2166. https://doi.org/10.1210/jc.2017-02344CrossRefPubMed

53.

Ford EA, Beckett EL, Roman SD et al (2020) Advances in human primordial follicle activation and premature ovarian insufficiency. Reproduction 159(1):R15–R29. https://doi.org/10.1530/REP-19-0201CrossRefPubMed

54.

Li H, Wang X, Mu H et al (2022) Mir-484 contributes to diminished ovarian reserve by regulating granulosa cell function via yap1-mediated mitochondrial function and apoptosis. Int J Biol Sci 18(3):1008–1021. https://doi.org/10.7150/ijbs.68028CrossRefPubMedPubMedCentral

55.

Zhang K, Zhong W, Li WP et al (2017) Mir-15a-5p levels correlate with poor ovarian response in human follicular fluid. Reproduction 154(4):483–496. https://doi.org/10.1530/rep-17-0157CrossRefPubMed

56.

Karakaya C, Guzeloglu-Kayisli O, Uyar A et al (2015) Poor ovarian response in women undergoing in vitro fertilization is associated with altered microrna expression in cumulus cells. Fertil Steril 103(6):1469–1476. https://doi.org/10.1016/j.fertnstert.2015.02.035. (e1461-1463)CrossRefPubMedPubMedCentral

57.

Chen X, Ba Y, Ma L et al (2008) Characterization of micrornas in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006. https://doi.org/10.1038/cr.2008.282CrossRefPubMed

58.

Abu-Halima M, Becker LS, Ayesh BM et al (2021) Characterization of micro-rna in women with different ovarian reserve. Sci Rep 11(1):13351. https://doi.org/10.1038/s41598-021-92901-wCrossRefPubMedPubMedCentral

59.

Belguith I, Dhieb D, Turki M et al (2022) Diagnostic value of mir-199a and mir-21 in the plasma of infertile women with dysregulated amh levels. Hum Fertil (Camb) 25(1):154–165. https://doi.org/10.1080/14647273.2020.1750715CrossRefPubMed

60.

Khan HL, Bhatti S, Abbas S et al (2021) Extracellular micrornas: key players to explore the outcomes of in vitro fertilization. Reprod Biol Endocrinol 19(1):72. https://doi.org/10.1186/s12958-021-00754-9CrossRefPubMedPubMedCentral

61.

Fàbregues F, Ferreri J, Méndez M et al (2020) In vitro follicular activation and stem cell therapy as a novel treatment strategies in diminished ovarian reserve and primary ovarian insufficiency. Front Endocrinol (Lausanne) 11:617704. https://doi.org/10.3389/fendo.2020.617704CrossRefPubMed

62.

Ding C, Qian C, Hou S et al (2020) Exosomal mirna-320a is released from hamscs and regulates sirt4 to prevent reactive oxygen species generation in poi. Mol Ther Nucl Acids 21:37–50. https://doi.org/10.1016/j.omtn.2020.05.013CrossRef

63.

Sun B, Ma Y, Wang F et al (2019) Mir-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis. Stem Cell Res Ther 10(1):360. https://doi.org/10.1186/s13287-019-1442-3CrossRefPubMedPubMedCentral

64.

Yang M, Lin L, Sha C et al (2020) Bone marrow mesenchymal stem cell-derived exosomal mir-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting pten. Lab Invest 100(3):342–352. https://doi.org/10.1038/s41374-019-0321-yCrossRefPubMed

65.

Xiao GY, Cheng CC, Chiang YS et al (2016) Exosomal mir-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy. Sci Rep 6:23120. https://doi.org/10.1038/srep23120CrossRefPubMedPubMedCentral

66.

Zhang Q, Sun J, Huang Y et al (2019) Human amniotic epithelial cell-derived exosomes restore ovarian function by transferring micrornas against apoptosis. Mol Ther Nucl Acids 16:407–418. https://doi.org/10.1016/j.omtn.2019.03.008CrossRef

67.

Ding C, Zhu L, Shen H et al (2020) Exosomal mirna-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating sirt7. Stem Cells 38(9):1137–1148. https://doi.org/10.1002/stem.3204CrossRefPubMed

68.

Gao T, Cao Y, Hu M et al (2022) Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying microrna-29a improves ovarian function of mice with primary ovarian insufficiency by targeting hmg-box transcription factor/wnt/β-catenin signaling. Dis Mark 2022:5045873. https://doi.org/10.1155/2022/5045873CrossRef

69.

Qu Q, Liu L, Cui Y et al (2022) Mir-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem Cell Res Ther 13(1):352. https://doi.org/10.1186/s13287-022-03056-yCrossRefPubMedPubMedCentral

70.

Yang W, Zhang J, Xu B et al (2020) Hucmsc-derived exosomes mitigate the age-related retardation of fertility in female mice. Mol Ther 28(4):1200–1213. https://doi.org/10.1016/j.ymthe.2020.02.003CrossRefPubMedPubMedCentral

71.

Du X, Li Q, Pan Z et al (2016) Androgen receptor and mirna-126* axis controls follicle-stimulating hormone receptor expression in porcine ovarian granulosa cells. Reproduction 152(2):161–169. https://doi.org/10.1530/rep-15-0517CrossRefPubMed

Titel: MicroRNAs in POI, DOR and POR
verfasst von: Jiali Luo
Zhaogui Sun
Publikationsdatum: 25.02.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 5/2023
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-023-06922-z

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

MicroRNAs in POI, DOR and POR

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Gynäkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

Antenatal corticosteroids and outcomes of small for gestational age infants born at 24–31 gestational weeks: a population-based propensity score matching analysis

Is there an association between levonorgestrel-releasing intrauterine system and breast cancer risk?

Outcomes of incomplete abortion related to treatment modality

The effect of normalizing vaginal microbiome using Lactovag in improving pregnancy outcomes in frozen embryo transfer cycles: a randomized clinical trial

Comment on “Microsatellite instability as a marker of prognosis: a systematic review and meta-analysis of endometrioid endometrial cancer survival data”

Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Gynäkologie